TetraLogic Pharmaceuticals Announces Exercise Of Over-Allotment Option

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MALVERN, Pa., Dec. 31, 2013 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that the underwriters for its initial public offering of common stock have exercised their option to purchase an additional 1,072,115 shares of common stock at a public offering price of $7.00 per share, before the underwriting discount. The closing of the option exercise occurred on December 31, 2013, resulting in net proceeds to TetraLogic of approximately $6,970,000 after the underwriting discount and offering costs.

Help employers find you! Check out all the jobs and post your resume.

Back to news